Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretation

被引:49
作者
Barnum, SR
Ames, RS
Maycox, PR
Hadingham, SJ
Meakin, J
Harrison, D
Parsons, AA
机构
[1] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
[2] Glaxo SmithKline, Dept Mol Biol, King Of Prussia, PA USA
[3] Glaxo SmithKline, Dept Neurosci Res, Harlow, Essex, England
关键词
stroke; inflammation; murine; neurons;
D O I
10.1002/glia.10069
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The receptors for the complement anaphylatoxins C3a and C5a are expressed by glial cells and neurons in normal and inflamed brain. Previous studies demonstrated modest elevations in mRNA expression of these receptors in a model of focal cerebral ischemia. Using a similar model system for both mice and rats, we report markedly different patterns of anaphylatoxin receptor mRNA expression in cerebral ischemia. C5a receptor expression was dramatically elevated within 3 h after middle cerebral artery occlusion, while C3aR expression was reduced to 25% of control animals. By 24 h post-occlusion, expression of both receptors was higher than at any other time point examined. This increased expression at late time points after occlusion is most likely the result of massive infiltration of leukocytes expressing the receptors. We also observed increased receptor mRNA expression in sham-operated animals, indicating that the procedures used for arterial occlusion affects mechanisms regulating receptor expression. This latter result highlights the importance of including this important control group in ischemic model systems for proper interpretation of changes in gene expression. GLIA 38:169-173, 2002. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 14 条
  • [1] Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia
    Connolly, ES
    Winfree, CJ
    Stern, DM
    Solomon, RA
    Pinsky, DJ
    [J]. NEUROSURGERY, 1996, 38 (03) : 523 - 531
  • [2] Davoust N, 1999, GLIA, V26, P201, DOI 10.1002/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO
  • [3] 2-M
  • [4] Complement components of the innate immune system in health and disease in the CNS
    Gasque, P
    Dean, YD
    McGreal, EP
    VanBeek, J
    Morgan, BP
    [J]. IMMUNOPHARMACOLOGY, 2000, 49 (1-2): : 171 - 186
  • [5] The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischemia - caspase-3 as a case study
    Harrison, DC
    Medhurst, AD
    Bond, BC
    Campbell, CA
    Davis, RP
    Philpott, KL
    [J]. MOLECULAR BRAIN RESEARCH, 2000, 75 (01): : 143 - 149
  • [6] Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein
    Huang, J
    Kim, LJ
    Mealey, R
    Marsh, HC
    Zhang, Y
    Tenner, AJ
    Connolly, ES
    Pinsky, DJ
    [J]. SCIENCE, 1999, 285 (5427) : 595 - 599
  • [7] REVERSIBLE MIDDLE CEREBRAL-ARTERY OCCLUSION WITHOUT CRANIECTOMY IN RATS
    LONGA, EZ
    WEINSTEIN, PR
    CARLSON, S
    CUMMINS, R
    [J]. STROKE, 1989, 20 (01) : 84 - 91
  • [8] The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models
    Medhurst, AD
    Harrison, DC
    Read, SJ
    Campbell, CA
    Robbins, MJ
    Pangalos, MN
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2000, 98 (01) : 9 - 20
  • [9] Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3
    Mukherjee, P
    Pasinetti, GM
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 77 (01) : 43 - 49
  • [10] Complement anaphylatoxin receptors on neurons: new tricks for old receptors?
    Nataf, S
    Stahel, PF
    Davoust, N
    Barnum, SR
    [J]. TRENDS IN NEUROSCIENCES, 1999, 22 (09) : 397 - 402